World's Best Scientists 2026 revealed!

D-Index & Metrics

Chemistry

D-Index
56
Citations
17612
World Ranking
11437
National Ranking
647

Paul D. Leeson publication distribution in Chemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Chemistry in 2026. The highlighted bar marks where Paul D. Leeson sits on this spectrum.

61–80 publications: 66 scientists 81–100 publications: 302 scientists 101–120 publications: 623 scientists 121–140 publications: 918 scientists 141–160 publications: 1,218 scientists 161–180 publications: 1,350 scientists 181–200 publications: 1,344 scientists 201–220 publications: 1,281 scientists 221–240 publications: 1,216 scientists 241–260 publications: 1,100 scientists 261–280 publications: 979 scientists 281–300 publications: 939 scientists 301–320 publications: 764 scientists 321–340 publications: 643 scientists 341–360 publications: 628 scientists 361–380 publications: 522 scientists 381–400 publications: 459 scientists 401–420 publications: 397 scientists 421–440 publications: 327 scientists 441–460 publications: 270 scientists 461–480 publications: 265 scientists 481–500 publications: 252 scientists 501–520 publications: 201 scientists 521–540 publications: 185 scientists 541–560 publications: 148 scientists 561–580 publications: 148 scientists 581–600 publications: 132 scientists 601–620 publications: 114 scientists 621–640 publications: 104 scientists 641–660 publications: 91 scientists 661–680 publications: 92 scientists 681–700 publications: 73 scientists 701–720 publications: 57 scientists 721–740 publications: 54 scientists 741–760 publications: 67 scientists 761–780 publications: 45 scientists 781–800 publications: 46 scientists 801–820 publications: 39 scientists 821–840 publications: 32 scientists 841–860 publications: 36 scientists 861–880 publications: 29 scientists 881–900 publications: 26 scientists 901–920 publications: 24 scientists 921–940 publications: 14 scientists 941–960 publications: 23 scientists 961–980 publications: 28 scientists 981–1,000 publications: 15 scientists 1,001–1,020 publications: 29 scientists 1,021–1,040 publications: 12 scientists 1,041–1,060 publications: 19 scientists 1,061–1,080 publications: 12 scientists 1,081–1,100 publications: 6 scientists 1,101–1,120 publications: 8 scientists 1,121–1,140 publications: 12 scientists 1,141–1,160 publications: 5 scientists 1,161–1,180 publications: 6 scientists 1,181–1,200 publications: 14 scientists 1,201–1,220 publications: 7 scientists 1,221–1,240 publications: 2 scientists 1,241–1,260 publications: 6 scientists 1,261–1,280 publications: 4 scientists 1,281–1,294 publications: 6 scientists 1,295+ publications: 100 scientists
61 publications 1,295+

This scientist: 161 publications — 18th percentile

18% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,295 publications or more.

Paul D. Leeson D-index placement in Chemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Chemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Paul D. Leeson sits on this spectrum.

40–41 D-Index: 289 scientists 42–43 D-Index: 612 scientists 44–45 D-Index: 808 scientists 46–47 D-Index: 776 scientists 48–49 D-Index: 835 scientists 50–51 D-Index: 861 scientists 52–53 D-Index: 872 scientists 54–55 D-Index: 933 scientists 56–57 D-Index: 1,051 scientists 58–59 D-Index: 930 scientists 60–61 D-Index: 882 scientists 62–63 D-Index: 834 scientists 64–65 D-Index: 731 scientists 66–67 D-Index: 775 scientists 68–69 D-Index: 683 scientists 70–71 D-Index: 646 scientists 72–73 D-Index: 561 scientists 74–75 D-Index: 501 scientists 76–77 D-Index: 437 scientists 78–79 D-Index: 388 scientists 80–81 D-Index: 354 scientists 82–83 D-Index: 292 scientists 84–85 D-Index: 275 scientists 86–87 D-Index: 254 scientists 88–89 D-Index: 235 scientists 90–91 D-Index: 185 scientists 92–93 D-Index: 192 scientists 94–95 D-Index: 155 scientists 96–97 D-Index: 163 scientists 98–99 D-Index: 125 scientists 100–101 D-Index: 105 scientists 102–103 D-Index: 105 scientists 104–105 D-Index: 112 scientists 106–107 D-Index: 88 scientists 108–109 D-Index: 68 scientists 110–111 D-Index: 69 scientists 112–113 D-Index: 65 scientists 114–115 D-Index: 79 scientists 116–117 D-Index: 61 scientists 118–119 D-Index: 44 scientists 120–121 D-Index: 37 scientists 122–123 D-Index: 40 scientists 124–125 D-Index: 33 scientists 126–127 D-Index: 26 scientists 128–129 D-Index: 34 scientists 130–131 D-Index: 35 scientists 132–133 D-Index: 25 scientists 134–135 D-Index: 27 scientists 136–137 D-Index: 17 scientists 138–139 D-Index: 16 scientists 140–141 D-Index: 20 scientists 142–143 D-Index: 20 scientists 144–145 D-Index: 15 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 9 scientists 150–151 D-Index: 16 scientists 152–153 D-Index: 11 scientists 154–155 D-Index: 9 scientists 156–157 D-Index: 3 scientists 158 D-Index: 3 scientists 159+ D-Index: 98 scientists
40 D-Index 159+

This scientist: 56 D-Index — 36th percentile

36% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 159 D-Index or more.

Overview

Paul D. Leeson is affiliated with Loughborough University in the United Kingdom and has contributed to several research topics within the field of Medicine. Their work primarily intersects with Computational Drug Discovery Methods and Microbial Natural Products and Biosynthesis, with additional focus on Pharmacogenetics and Drug Metabolism, Receptor Mechanisms and Signaling, Click Chemistry and Applications, Chemical Synthesis and Analysis, and Biochemical and Structural Characterization.

The scientist's frequent coauthors include Andrew R. Leach, Robert J. Young, Herbert Waldmann, Anna Lina Heinzke, and Axel Pahl. Their research has been published mainly in the Journal of Medicinal Chemistry, with other contributions appearing in JACS Au and Scientific Data, among additional venues such as the European Journal of Preventive Cardiology and Open Heart.

Leeson's recent papers comprise:

  • Target-Based Evaluation of "Drug-Like" Properties and Ligand Efficiencies, 2021, Journal of Medicinal Chemistry
  • The Time and Place for Nature in Drug Discovery, 2022, JACS Au
  • Occurrence of "Natural Selection" in Successful Small Molecule Drug Discovery, 2024, Journal of Medicinal Chemistry
  • Pseudonatural Products for Chemical Biology and Drug Discovery, 2025, Journal of Medicinal Chemistry
  • A compound-target pairs dataset: differences between drugs, clinical candidates and other bioactive compounds, 2024, Scientific Data

Leeson's scholarly output is anchored in several subfields including Computational Theory and Mathematics, Pharmacology, Molecular Biology, Cardiology and Cardiovascular Medicine, and Organic Chemistry. The integration of computational approaches with chemical and biological techniques characterizes the scope of their research efforts.

Best Publications

  • The influence of drug-like concepts on decision-making in medicinal chemistry

    Paul D. Leeson;Brian Springthorpe

  • An analysis of the attrition of drug candidates from four major pharmaceutical companies

    Michael J. Waring;John Arrowsmith;Andrew R. Leach;Paul D. Leeson

  • The role of ligand efficiency metrics in drug discovery

    Andrew L. Hopkins;György M. Keserü;Paul D. Leeson;David C. Rees

  • The Design of Leadlike Combinatorial Libraries.

    Simon J. Teague;Andrew M. Davis;Paul D. Leeson;Tudor Oprea

  • Is There a Difference between Leads and Drugs? A Historical Perspective

    Tudor I. Oprea;Andrew M. Davis;Simon J. Teague;Paul D. Leeson

  • 7-Chlorokynurenic acid is a selective antagonist at the glycine modulatory site of the N-methyl-D-aspartate receptor complex.

    J A Kemp;A C Foster;P D Leeson;T Priestley

  • A comparison of physiochemical property profiles of development and marketed oral drugs.

    Mark C. Wenlock;Rupert P. Austin;Patrick Barton;and Andrew M. Davis

  • The glycine site of the NMDA receptor — five years on

    John A. Kemp;Paul D. Leeson

  • The glycine site on the NMDA receptor: structure-activity relationships and therapeutic potential.

    Paul D. Leeson;Leslie L. Iversen

  • Time-related differences in the physical property profiles of oral drugs.

    Paul D Leeson;Andrew M Davis

  • Drug discovery: Chemical beauty contest

    Paul Leeson

  • 3-((4-(4-Chlorophenyl)piperazin-1-yl)-methyl)-1H-pyrrolo-2,3-b-pyridine: an antagonist with high affinity and selectivity for the human dopamine D4 receptor.

    J J Kulagowski;H B Broughton;N R Curtis;I M Mawer

  • From ATP to AZD6140: the discovery of an orally active reversible P2Y12 receptor antagonist for the prevention of thrombosis.

    Brian Springthorpe;Andrew Bailey;Patrick Barton;Timothy N. Birkinshaw

  • 4-Amido-2-carboxytetrahydroquinolines. Structure-activity relationships for antagonism at the glycine site of the NMDA receptor.

    P D Leeson;R W Carling;K W Moore;A M Moseley

  • Kynurenic acid derivatives. Structure-activity relationships for excitatory amino acid antagonism and identification of potent and selective antagonists at the glycine site on the N-methyl-D-aspartate receptor.

    Paul D. Leeson;Raymond Baker;Robert W. Carling;Neil R. Curtis

  • [ 3 H]L-655,708, a Novel Ligand Selective for the Benzodiazepine Site of GABA A Receptors which Contain the α5 Subunit

    K. Quirk;P. Blurton;S. Fletcher;P. Leeson

  • The influence of the 'organizational factor' on compound quality in drug discovery

    Paul D. Leeson;Stephen A. St-Gallay

  • Biological Profile of L-745,870, a Selective Antagonist with High Affinity for the Dopamine D4 Receptor

    S. Patel;S. Freedman;K. L. Chapman;F. Emms

  • Molecular inflation, attrition and the rule of five.

    Unknown

  • Enantiomers of HA-966 (3-amino-1-hydroxypyrrolid-2-one) exhibit distinct central nervous system effects: (+)-HA-966 is a selective glycine/N-methyl-D-aspartate receptor antagonist, but (-)-HA-966 is a potent gamma-butyrolactone-like sedative

    L Singh;A E Donald;A C Foster;P H Hutson

  • 3-phenyl-6-(2-pyridyl)methyloxy-1,2,4-triazolo[3,4-a]phthalazines and analogues: high-affinity gamma-aminobutyric acid-A benzodiazepine receptor ligands with alpha 2, alpha 3, and alpha 5-subtype binding selectivity over alpha 1.

    Robert W Carling;Kevin W Moore;Leslie J Street;Deborah Wild

Frequent Co-Authors

Raymond Baker
Raymond Baker MSD (United States)
Michael Rowley
Michael Rowley Pharmaron (United Kingdom)
Ian Collins
Ian Collins PharmEnable Therapeutics
Andrew M. Davis
Andrew M. Davis University of Chicago
Ruth M. McKernan
Ruth M. McKernan MSD (United States)
Richard G. Ball
Richard G. Ball MSD (United States)
Robert M. Owen
Robert M. Owen University of Michigan–Ann Arbor
Miles Congreve
Miles Congreve University of Hertfordshire
Jonathan B. Baell
Jonathan B. Baell Monash University
Richard Hargreaves
Richard Hargreaves Harvard Medical School

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a Chemistry degree in the USA can open doors to various interdisciplinary fields, including forensic science and criminal justice. Many students interested in applying chemical principles to real-world problems may consider exploring online colleges for forensic science. These programs often provide specialized knowledge in analyzing evidence and understanding chemical processes in criminal investigations.

For those aiming to deepen their expertise, an online masters forensic psychology degree offers a unique blend of psychological insight and forensic application, helping graduates work effectively within the justice system.

Understanding the forensic careers landscape reveals diverse opportunities, from crime lab analysis to expert testimony roles. These paths often require strong scientific backgrounds combined with practical experience in legal settings.

While exploring these options, it's important to consider program costs and value. Reviewing information on how much is a criminal justice degree can help you budget effectively and choose the best educational route to align with your career goals.

Best Scientists Citing Paul D. Leeson

Trending Scientists

Recently Published Articles